GKIM
ANGO icon

GW&K Investment Management’s AngioDynamics ANGO Stock Holding History

GW&K Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,095
Closed -$491K – 287
2018
Q2 		$491K Buy
22,095
+1,510
+7% +$30.9K 0.01% 241
2018
Q1 		$355K Buy
20,585
+5,760
+39% +$96.1K 0.01% 255
2017
Q4 		$247K Buy
14,825
+1,645
+12% +$28.1K ﹤0.01% 248
2017
Q3 		$225K Buy
13,180
+325
+3% +$5.46K ﹤0.01% 243
2017
Q2 		$208K Buy
+12,855
New +$203K ﹤0.01% 233

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

GW&K Investment Management's ANGO Position: Q3 2018 in Review

GW&K Investment Management sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 22,095 shares — an estimated $491K sold.

GW&K Investment Management first reported a position in ANGO in Q2 2017 and held it in 5 quarters. The position peaked at $491K in Q2 2018. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

  • GW&K Investment Management reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
  • GW&K Investment Management sold 22,095 AngioDynamics shares in Q3 2018, an estimated $491K.
  • GW&K Investment Management first reported a position in AngioDynamics in Q2 2017 and held it in 5 quarters.
  • GW&K Investment Management's AngioDynamics position peaked at $491K in Q2 2018.
  • 177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on GW&K Investment Management's 13F filing for Q3 2018, filed 6 Nov 2018.